Summary We have utilized the blast cell assay of Buick et al. (1977) 
The recent development of in vitro assays for growth of human leukaemic clonogenic cells has greatly increased our knowledge of cell renewal systems (Metcalf, 1977) . However, few studies have analyzed the cytogenetic profile of the clonogenic cells, to obtain direct confirmation of the neoplastic nature of the stem/progenitor cell population (Moore & Metcalf, 1973; Dube et al., 1981; Lowenberg et al., 1980) . Recent evidence suggests that differences in leukaemic culture assays (direct or clonogenic) may provide growth advantage to selected cell populations, thus making a direct comparison of results from different culture techniques difficult (Knuutila et al., 1981) .
We have investigated the cytogenetic and cytokinetic characteristics of marrow and blood cells from AML and CML patients by direct techniques and compared these properties to those observed in CFUs grown in the methylcellulose assay of Buick et al. (1977) . Our results strongly suggest that CFUs grown in this assay are derived from true leukaemic progenitors and reflect the inherent biologic nature of a patient's leukaemic cells (as measured by karyology and tritiated thymidine [3H]-dT labelling index [LI] ).
Additionally, our results suggest this assay provides a simple and reproducible means of analyzing the cytogenetic profile of leukaemic CFUs.
Materials and methods

Cytogenetics
Cells were harvested for cytogenetic analysis using a modification of the technique of Trent & Salmon (1980) . Briefly, CFUs were allowed to grow for 72-96h in 7.5% CO2. Colcemid (0.05pg/ml) was added the last 4-12 h of culture. Clusters or colonies were then removed from the plates, washed free of methylcellulose with fresh medium, and placed into hypotonic (0.075 M KCl prewarmed to 37°C) for 25 min. Following centrifugation (150 x g, 5 min), the supernatant was removed and 5 ml of fresh cold fixative (3:1 methanol:glacial acetic acid) was added with vigorous vortex agitation. Cultures were then washed twice more with fixative and stored at -9°C. Air-dried slides were prepared and cells banded by G- (Sun et al., 1973) or C- (Miller et al., 1976) banding techniques. Chromosome harvesting of direct bone marrows was performed utilizing direct and short term liquid culture techniques (Morse et al., 1977; Shiloh &.Cohen, 1978) .
All chromosome changes listed are "clonal" alterations according to ISCN (1978) (Buick et al., 1977) . Cultures were then incubated at 37°C in a humidified atmosphere of 5% CO2 with air for 7 days. Plates were examined for growth and categorized as no growth, minimal growth (e.g., cell doublings), clusters (<30 cells), or colonies (>30 cells). Routine morphologic and histochemical analysis with Wright-Giemsa, Sudan Black B and chloracetate esterase staining was also used to confirm the leukaemic nature of colonies.
litiated thymidine labelling of plated leukaemic cells Bone marrow (1-3 ml) was aspirated aseptically into a syringe containing sodium heparin. One-quarter volume of 3% dextran was then added to each sample in order to sediment red cells. The supernatant plasma (which was contained in the marrow cells) was transferred to a sterile centrifuge tube and diluted to 45 ml with Hank's Balanced Salt Solution with 10% fetal bovine serum (HBSS-FBS) and centrifuged 10 min at 600xg. The cell button was then resuspended in HBSS-FBS, with the centrifugation and cell washing procedure repeated twice. A 2-ml aliquot of the washed cell suspension was placed in a sterile plastic tissue culture tube and warmed to 37°C in a waterbath. Five 4uCi of [3H]-dT (specific activity, 40-60 Ci/mM) was added to the cell suspension. After 1 h of incubation, the suspension was washed free of the unincorporated [3H]-dT by 2 additional washes with HBSS-FBS. Following incubation, cell preparations were free of clumping and had a viability of > 98%. Slides for autoradiography and microscopic examination were prepared utilizing a cytocentrifuge. Slides for autoradiography were then dipped in Kodak NTB-3 emulsion and further processed using high speed scintillation autoradiography (HSARG) (Durie & Salmon, 1975) . Routinely, duplicate slides were exposed for 6 h and 24 h and without scintillator and compared with conventional autoradiography ([3H]-dt, 18 Ci/mM exposure, 7 days, 2°C). No significant differences were found in final labelling indices (Durie & Salmon, 1975) . Readings of slides processed using the HSARG technique and exposed for 24h were used in this analysis.
Following developing of slides, each slide was stained with acid Giemsa stain. Autoradiographs prepared in this fashion were of high quality with a background median grain count of <35 grains/100 cells. Cells containing >5 grains over the nucleus were considered labelled. One thousand cells were counted in order to determine the LI, which was expresssed as a percentage. The median grain count of labelled leukaemic cells measured with this LI technique was .50 grains/cell nucleus. Statistical considerations regarding threshold grain counts and relation to background were as described by Clarkson et al. (1967) .
Patient population A total of 46 patients had bone marrow and/or peripheral blood samples referred to our laboratories for direct cytogenetic analysis and clonal assay. Of these, 7 had CML in the chronic or blastic phase, the remaining 39 having AML which was categorized using the FAB classification (Gralnick et al., 1977) . The patients in this study ranged in age from 12-74 years. Of 39 AML patients, 31 were classified as M1 or M2; 6 as M4; and one each M3 and M6. Eight patients were previously untreated with the remainder being evaluated at the time of first or later relapse. Drug treatment of these patients will be reported elsewhere (Durie et al., submitted for publication).
Results
We compared the success rate of obtaining analyzable mitoses from direct marrow cells and leukaemic CFUs. Forty-one of 46 (91.1%) of direct marrows and 30/36 (83.3%) methylcellulose cultures provided sufficient mitoses for cytogenetic analysis. This difference was not statistically different (n=72, P =0.40). As examples, comparison of the chromosome banding patterns of direct marrows and CFUs from 5 patients with AML and one patient with Ph' positive CML are described. One AML patient was studied twice over a 6-month period. Clinical and cytogenetic assessments of each of these patients are presented in Tables I and II. Cytogenetic analysis of patients presenting with an abnormal karyotype revealed the presence of identical clonal chromosomal abnormalities in direct harvests and CFUs (Table 2, Figures 1-3) . However, karyotypically normal mitoses (with or without E-rosette depletion prior to culture) were also observed in cultures from all 5 AML patients (Table II) . We have found no consistent change in the ratio of normal:abnormal cells in direct vs. chromosome involved, and breakpoints of the translocation: t(1; 12)(1qter-+ lq21.: 12pl3 -12qter) (Figures 1 and 2) .
Characterization of AML colony-forming cells was also derived from examining the relationship between growth in methylcellulose, with LI and/or karyotype. Twenty-three patients were evaluated for LI and subsequently for colony growth. A highly significant correlation existed between a high LI ((>5%) and leukaemic colony formation (P=0.018) (Table III) . Similarly, when the karyotype of direct marrows was correlated for growth of leukemic CFUs, a high correlation existed between the presence of any karyotypically abnormal clone and colony growth (P=0.010) (Table III) . When the LI and karyotype for samples with or without leukaemic colonies were cross-correlated, no significant difference was observed (P = 0.80; 0.20, respectively). However, this apparent lack of correlation is explained when leukaemic colony growth and LI (%) were compared from chromosomally normal and abnormal cases. A highly significant correlation existed between growth and high LI for chromosomally abnormal samples (P=0.018), while chromosomally normal samples did not demonstrate a significant correlation (P=0.28) ( Table III) .
Because of the possibility of significant differences between bone marrow and blood CFUs from the same patient, results from marrow and peripheral blood CFUs were compared. In 4 patients, cytogenetics and LI could be compared from both blood and marrow samples. Karyotype (normal or abnormal) and LI did not differ between sample sites in any of these patients. One additional patient had CFUs from the peripheral blood only and therefore could not be compared. The proportion of cases studied for karyotype or LI versus growth in this assay was similar with or without samples derived from peripheral blood. 
Discussion
The success rate in our laboratory of obtaining analyzable mitoses from leukemic CFUs was similar to that observed in our laboratory for direct harvesting techniques. However, the requirement of greatly increased sample preparation, coupled with the time-consuming nature of cytogenetic analysis, would appear to make utilization of this colony assay for routine cytogenetic analysis too laborious. Also, in contrast to recent reports utilizing liquid culture (Knuutila et al., 1981) , we have been unable to recognize clonal subpopulations in CML or AML unique to or with increased frequency in colony-forming cells. Thus, although the mitotic index of samples was often increased from CFUs, identification of clonal subpopulations was not increased. However, the colony assay was very useful in providing large numbers of mitotic cells suitable for detailed chromosome banding analysis.
Cytogenetic examination of CML in blast crisis (case 6) revealed only the presence of Ph' positive cells (Figure 3) . With one exception, (Sonoda et al., 1980) , these results are similar to previous reports of CFUs from patients with CML (Chervenick et al., 1971; Moore & Metcalf, 1973) . Of perhaps more interest was the consistent finding in AML patients of karyotypically "normal" cells from cultures also displaying colonies with an abnormal karyotype (Table II, cases 2-5). Although we cannot exclude the possibility of non-leukaemic CFUs growing in this system, it is possible that these karyotypically "normal" mitoses may, in fact, have been of leukaemic origin and harbor subtle chromosomal rearrangements unrecognized with current techniques. Utilizing prometaphase chromosomes, Yunis et al. (1981) has recently suggested that 100% of acute non-lymphocytic leukaemia patients display a cytogenetic abnormality. We are currently adapting this methodology to colony cells to determine whether an increased percentage of CFUs with chromosomal abnormalities can be identified. Additionally, we are beginning cytogenetic analysis of single colonies which may provide further information on the nature of CFU growth in this assay.
Of major interest is our finding in AML patients that karyotypically abnormal and/or high LI had the highest percentage of growth in this blast cell assay (Table III) . These results support previous findings from this laboratory on multiple myeloma (Durie et al., in press) , suggesting that the clonogenic fraction is largely derived from cycling marrow cells. These results may also explain the relationship of normal to leukaemic cell growth in agar culture observed in other assays Spitzer et al., 1979) . Verma et al. (1979) suggested that PHA-stimulated patients with only normal CFU-C growth (therefore negative for leukaemic growth) in agar culture display a prognostic advantage over patients with a high fraction of leukaemic colonies. Although we have not yet directly correlated our results on colony formation and survival, it is well known that the presence of karyotypically abnormal clones (Shiraishi et al., 1982) or high labelling index (Durie, 1982) are indicators of poor patient prognosis. It is possible that our low LI-karyotypically normal population is similar to the category I-A (good prognosis) patients reported by Spitzer et al. (1979) .
We feel that the cytogenetic and cytokinetic evidence presented in this report provides strong support for the leukaemic nature of CFUs grown in the clonal assay of Buick et al. (1977) . This assay may provide a valuable means of providing a large number of leukaemic metaphases for detailed cytogenetic analysis.
